Abstract:Background Frailty is common in patients admitted with acute decompensation of heart failure (ADHF) and it is unclear how the frailty syndrome affects heart failure (HF) patients during their acute hospital admission. Understanding the interplay between frailty, impaired renal function, hospital-acquired infections (HAI), and death may be useful in optimising patient care and prognosis. Purpose The aim of this analysis was to explore the relationship between admission frailty levels and the incidence of HAI, acute kidney injury (AKI), and mortality in acute HF hospital admissions. Methods This is a retrospective analysis of data submitted from a single centre to the National HF audit between January and June 2023. Additional frailty and baseline renal function data was retrospectively collected from electronic patient health records. Patients were categorised into three groups according to their Rockwood Clinical Frailty Scale (CSF) (1): no/mild frailty (CFS 1-3), moderate frailty (CFS 4-6) and severe frailty (CFS 7-9). AKI was defined based on baseline and admission creatinine, as per KDIGO guidelines (2). Chi-squared and t-tests were used to compare baseline characteristics between frailty groups. Chi-squared tests were used to compare frailty groups in terms of: HAI, AKI, mortality. Results Between 1st January and 22nd June 2023, there were 344 acute HF hospital admissions in our centre. Most patients had moderate frailty on admission (n=256, 74.4%). Frail patients were significantly older, had a lower admission mean haemoglobin and more were female, compared to non-frail patients (Figure 1A). Patients who were more frail were more likely to experience HAI during their admission; p=0.035 (figure 1B). Furthermore, patients with HAI had a greater risk of mortality, at a median follow-up of 171 (IQR 100.25) days after admission, compared to those without HAI (p>0.001). 41.9% of acute HF admissions were associated with an AKI, and although numerically more frail patients had an AKI, this did not achieve statistical significance (p=0.084). Patients who were more frail were more likely to die, both during hospital admission and at 3 months following discharge; p<0.001 (Figure 1B). Furthermore, this trend persisted after follow-up; p<0.001 (Figure 2). Conclusions Patients with moderate or severe frailty are at greater risk of adverse events (HAI, death) during an acute HF hospital admission, than patients with no or mild frailty. It is imperative to consider the frailty status of all patients with ADHF, to be aware of the frailty-associated risks, and act proactively with targeted interventions (screen for infections, daily bloods, early conversations with patients and their families about treatment escalation plans and patient priorities) to improve outcomes and enhance the quality of care for this vulnerable patient population. Further research is warranted to explore potential interventions to address frailty-related risks in HF management.

Frailty according to the 2019 HFA‐ESC definition in patients at risk for advanced heart failure: Insights from the HELP‐HF registry

Frailty in chronic heart failure: a multidimensional assessment of older patients undergoing cardiac rehabilitation

Frailty and heart failure: State-of-the-art review

The Dual Burden of Frailty and Heart Failure

Prevalence and prognostic impact of frailty and its components in non-dependent elderly patients with heart failure

Frailty Assessment Scale for Heart Failure

Physical frailty and long-term mortality in older people with chronic heart failure with preserved and reduced ejection fraction: a retrospective longitudinal study

The burden of frailty in heart failure: Prevalence, impacts on clinical outcomes and the role of heart failure medications

Frailty and outcomes in heart failure patients from high-, middle-, and low-income countries

Clinical and Psychological Factors Associated with Frailty in Patients with Heart Failure

Frailty and Post-hospitalization Outcomes in Patients with Heart Failure with Preserved Ejection Fraction

The association between chronic heart failure and frailty index: A study based on the National Health and Nutrition Examination Survey from 1999 to 2018

The association between frailty and in-hospital mortality in critically ill patients with congestive heart failure: results from MIMIC-IV database

Frailty in heart failure according to the presence or absence of wild-type transthyretin cardiac amyloidosis

Frailty is associated with 90-day unplanned readmissions and death in patients with heart failure: A longitudinal study in China

Sacubitril/Valsartan and Frailty in Patients with Heart Failure and Preserved Ejection Fraction

The prevalence of frailty and its effect on the outcome in cardiac resynchronization therapy patients

Frailty related all-cause mortality or hospital readmission among adults aged 65 and older with stage-B heart failure inpatients

Prevalence and prognostic impact of the coexistence of multiple frailty domains in elderly patients with heart failure: the FRAGILE‐HF cohort study

Epidemiology and impact of frailty in patients with atrial fibrillation in Europe

Increased frailty is associated with risk of hospital-acquired infections and death during heart failure hospital admissions